Search

Your search keyword '"Bosly, André"' showing total 6 results
Start Over Author "Bosly, André" Journal leukemia & lymphoma
6 results on '"Bosly, André"'

1. Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study

Author

Drach, Johannes, primary, Huang, Huiqiang, additional, Samoilova, Olga, additional, Belch, Andrew, additional, Farber, Charles, additional, Bosly, André, additional, Novak, Jan, additional, Zaucha, Jan, additional, Dascalescu, Angela, additional, Bunworasate, Udomsak, additional, Masliak, Zvenyslava, additional, Vilchevskaya, Kateryna, additional, Robak, Tadeusz, additional, Pei, Lixia, additional, Rooney, Brendan, additional, van de Velde, Helgi, additional, and Cavalli, Franco, additional

Published
2018
Full Text
View/download PDF

2. Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma

Author

Nols, Nathalie, primary, Mounier, Nicolas, additional, Bouazza, Salima, additional, Lhommel, Renaud, additional, Costantini, Sabrina, additional, Vander Borght, Thierry, additional, Vekemans, Marie-Christiane, additional, Sonet, Anne, additional, Bosly, André, additional, Michaux, Lucienne, additional, André, Marc, additional, and Van Den Neste, Eric, additional

Published
2013
Full Text
View/download PDF

3. Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma

Author

Jardin, Fabrice, primary, Delfau-Larue, Marie Hélène, additional, Molina, Thierry Jo, additional, Copie-Bergman, Christiane, additional, Brière, Josette, additional, Petrella, Tony, additional, Canioni, Danielle, additional, Fabiani, Bettina, additional, Jais, Jean-Philippe, additional, Figeac, Martin, additional, Leroy, Karen, additional, Mareschal, Sylvain, additional, Salles, Gilles André, additional, Coiffier, Bertrand, additional, Delarue, Richard, additional, Peyrade, Frédéric, additional, Bosly, André, additional, André, Marc, additional, Ketterer, Nicolas, additional, Haioun, Corinne, additional, and Tilly, Hervé, additional

Published
2013
Full Text
View/download PDF

4. Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma.

Author

Nols, Nathalie, Mounier, Nicolas, Bouazza, Salima, Lhommel, Renaud, Costantini, Sabrina, Vander Borght, Thierry, Vekemans, Marie-Christiane, Sonet, Anne, Bosly, André, Michaux, Lucienne, André, Marc, and Van Den Neste, Eric

Subjects
B cell lymphoma, B cells, PROGNOSIS, HEALTH outcome assessment, POSITRON emission tomography, LYMPHOMAS
Abstract

The prognostic value of interim 18fluorodeoxyglucose positron emission tomography (i-PET) was investigated in 73 patients (median age 60 years) with diffuse large B-cell lymphoma (DLBCL). i-PET was analyzed using the Deauville score (DS) and change in maximum standardized uptake value (ΔSUVmax). Patients with a DS of 1-3 demonstrated a significantly ( p < 0.0001) better outcome (median follow-up 2.4 years) than patients with a score of 4 or 5 in terms of event-free survival (EFS) (79% vs. 36%), progression-free survival (PFS) (84% vs. 47%) and overall survival (OS) (91% vs. 51%). EFS (73% vs. 42%), PFS (78% vs. 50%) and OS (88% vs. 56%) were also significantly ( p = 0.023) different between patients with ΔSUVmax > 66% or ≤ 66%. Patients ( n = 33) combining a favorable age-adjusted International Prognostic Index (IPI) (0 or 1) and a negative i-PET either by DS or ΔSUVmax criteria showed a particularly good outcome (EFS: 85%, PFS: 88%, OS: 94%). Overall, i-PET was highly and independently predictive of any outcome, and its negative predictive value was improved by combination with IPI. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

5. Placebo-Controlled phase III Study of lenograstim (Glycosylated recombinant human granulocyte colony-Stimulating factor) in Aggressive non-Hodgkin's lymphoma: Factors influencing chemotherapy administration

Author

Gisselbrecht, Christian, primary, Haioun, Corinne, additional, Lepage, Eric, additional, Bastion, Yves, additional, Tilly, Hervé, additional, Bosly, André, additional, Dupriez, Brigitte, additional, Marit, Gerald, additional, Herbrecht, Raoul, additional, Deconinck, Eric, additional, Marolleau, Jean Pierre, additional, Yver, Antoine, additional, Dabouz-Harrouche, Farida, additional, Coiffier, Bertrand, additional, and Reyes, Felix, additional

Published
1997
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results